Association of a BMP9 haplotype with ossification of the posterior longitudinal ligament (OPLL) in a Chinese population.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3400650)

Published in PLoS One on July 19, 2012

Authors

Yuan Ren1, Zhi-zhong Liu, Jie Feng, Hong Wan, Jun-hua Li, Hao Wang, Xin Lin

Author Affiliations

1: Department of Orthopaedics, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China.

Articles cited by this

Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A (2006) 3.13

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55

An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol (2003) 2.53

Ossification of the posterior longitudinal ligament of the spine. Clin Orthop Relat Res (1984) 2.45

Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res (2007) 2.26

Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A (1988) 2.13

Polymerase chain reaction. Biotechniques (1988) 2.04

BMP-9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res (2011) 1.85

Ossification of the posterior longitudinal ligament: an update on its biology, epidemiology, and natural history. Neurosurgery (2006) 1.79

Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet (1999) 1.77

Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38

Genetic studies on ossification of the posterior longitudinal ligament of the spine. Spine (Phila Pa 1976) (1989) 1.32

COL6A1 polymorphisms associated with ossification of the ligamentum flavum and ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976) (2007) 1.25

High body mass index after age 20 and diabetes mellitus are independent risk factors for ossification of the posterior longitudinal ligament of the spine in Japanese subjects: a case-control study in multiple hospitals. Spine (Phila Pa 1976) (2004) 1.15

Ligamentous ossification of the cervical spine in the late middle-aged Japanese men. Its relation to body mass index and glucose metabolism. Spine (Phila Pa 1976) (1996) 1.12

Prevalence of ossification of the posterior longitudinal ligament of the cervical spine. Joint Bone Spine (2008) 1.09

Genetic study of ossification of the posterior longitudinal ligament in the cervical spine with human leukocyte antigen haplotype. Spine (Phila Pa 1976) (1991) 1.09

Recent progress in the study of pathogenesis of ossification of the posterior longitudinal ligament. J Orthop Sci (2000) 1.05

Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations. Blood (2010) 1.04

Association of bone morphogenetic protein-2 gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity in Chinese patients. Eur Spine J (2008) 1.00

Genetic analysis of ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976) (1999) 0.98

Dietary habits and risk of ossification of the posterior longitudinal ligaments of the spine (OPLL); findings from a case-control study in Japan. J Bone Miner Metab (2004) 0.97

Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery (2002) 0.96

Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg (2000) 0.95

Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol Ther (2010) 0.94

Cervical myelopathy associated with degenerative spine disease and ossification of the posterior longitudinal ligament. Semin Neurol (2002) 0.93

The extent of ossification of posterior longitudinal ligament of the spine associated with nucleotide pyrophosphatase gene and leptin receptor gene polymorphisms. Spine (Phila Pa 1976) (2005) 0.93

The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg (2000) 0.92

Association between polymorphism of the transforming growth factor-beta1 gene with the radiologic characteristic and ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976) (2003) 0.89

[Epidemiological study on ossification of the posterior longitudinal ligament (OPLL) in the cervical spine--comparison of the prevalence between Japanese and Taiwanese]. Nihon Seikeigeka Gakkai Zasshi (1990) 0.88

Family study of a twin with ossification of the posterior longitudinal ligament in the cervical spine. Spine (Phila Pa 1976) (1992) 0.86

Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine. J Bone Miner Metab (1999) 0.84

BMP-9-transduced prefabricated muscular flaps for the treatment of bony defects. J Craniofac Surg (2004) 0.81

Sleeping habit and other life styles in the prime of life and risk for ossification of the posterior longitudinal ligament of the spine (OPLL): a case-control study in Japan. J Epidemiol (2004) 0.79

[Ectopic bone formation of bone marrow mesenchymal stem cells with gene transfer of human bone morphogenetic protein-9 gene in rabbit]. Sichuan Da Xue Xue Bao Yi Xue Ban (2008) 0.78

T allele at site 6007 of bone morphogenetic protein-4 gene increases genetic susceptibility to ossification of the posterior longitudinal ligament in male Chinese Han population. Chin Med J (Engl) (2010) 0.78

[Updates on ossification of posterior longitudinal ligament. Epidemiology and pathogenesis of OPLL]. Clin Calcium (2009) 0.77

Articles by these authors

(truncated to the top 100)

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73

The accessible chromatin landscape of the human genome. Nature (2012) 16.86

Systematic localization of common disease-associated variation in regulatory DNA. Science (2012) 14.47

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med (2014) 12.29

Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36

An expansive human regulatory lexicon encoded in transcription factor footprints. Nature (2012) 7.27

The genome of woodland strawberry (Fragaria vesca). Nat Genet (2010) 5.86

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr (2007) 4.67

The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science (2009) 4.63

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol (2003) 4.44

Global regulation of erythroid gene expression by transcription factor GATA-1. Blood (2004) 4.22

LTR_FINDER: an efficient tool for the prediction of full-length LTR retrotransposons. Nucleic Acids Res (2007) 3.89

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol (2006) 3.76

A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol (2002) 3.38

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol (2003) 3.27

Reference genome sequence of the model plant Setaria. Nat Biotechnol (2012) 3.21

Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity (2005) 3.14

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol (2005) 3.12

De novo genome sequencing and comparative genomics of date palm (Phoenix dactylifera). Nat Biotechnol (2011) 2.94

A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell (2012) 2.81

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res (2013) 2.81

The genome of the pear (Pyrus bretschneideri Rehd.). Genome Res (2012) 2.55

Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. J Acquir Immune Defic Syndr (2010) 2.37

Diaqua-bis(5-carb-oxy-2-propyl-1H-imidazole-4-carboxyl-ato-κN,O)manganese(II) N,N-dimethyl-formamide disolvate. Acta Crystallogr Sect E Struct Rep Online (2009) 2.35

Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35

Drosophila liprin-alpha and the receptor phosphatase Dlar control synapse morphogenesis. Neuron (2002) 2.33

Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem (2006) 2.32

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg (2009) 2.31

Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer (2014) 2.24

Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. J Immunol (2009) 2.23

Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest (2007) 2.19

Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19

Antagonistic HLH/bHLH transcription factors mediate brassinosteroid regulation of cell elongation and plant development in rice and Arabidopsis. Plant Cell (2009) 2.17

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. Clin Infect Dis (2010) 2.14

Evaluation of terrestrial carbon cycle models for their response to climate variability and to CO2 trends. Glob Chang Biol (2013) 2.13

Ultrasound-guided peripheral intravenous access in the emergency department using a modified Seldinger technique. J Emerg Med (2009) 2.08

Defibrillation delivered during the upstroke phase of manual chest compression improves shock success. Crit Care Med (2010) 2.04

The effect of combined antihypertensive treatment (felodipine with either irbesartan or metoprolol) on erectile function: a randomized controlled trial. Cardiology (2013) 2.02

catena-Poly[[diaqua-(1,10-phenanthroline-κN,N')nickel(II)]-μ-1H-benzimidazole-5,6-dicarboxyl-ato-κN:O]. Acta Crystallogr Sect E Struct Rep Online (2009) 1.99

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol (2004) 1.96

Techniques for teaching electrocardiogram interpretation: self-directed learning is less effective than a workshop or lecture. Med Educ (2011) 1.95

Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis (2004) 1.92

Penta-aqua-(1H-benzimidazole-5,6-di-carboxyl-ato-κN)cobalt(II) penta-hydrate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.92

Highwire regulates presynaptic BMP signaling essential for synaptic growth. Neuron (2004) 1.91

Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol (2007) 1.89

Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl (2009) 1.86

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection. J Acquir Immune Defic Syndr (2009) 1.83

Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J Cell Biol (2007) 1.82

Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81

Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med (2012) 1.80

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. Lancet Infect Dis (2013) 1.78

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem (2004) 1.77

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. Clin Infect Dis (2011) 1.77

Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med (2011) 1.76

New best1 mutations in autosomal recessive bestrophinopathy. Retina (2015) 1.75

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer (2006) 1.72

Widespread site-dependent buffering of human regulatory polymorphism. PLoS Genet (2012) 1.72

Distal left main coronary bifurcation lesions predict worse outcome in patients undergoing percutaneous implantation of drug-eluting stents: results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study. Cardiology (2009) 1.68

Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol (2002) 1.68

Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion. Am J Hypertens (2011) 1.67

Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer (2010) 1.67

Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electrocardiol (2013) 1.66

Compound prioritization methods increase rates of chemical probe discovery in model organisms. Chem Biol (2011) 1.64

Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity (2004) 1.63

Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol (2013) 1.63

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med (2009) 1.62

Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol (2003) 1.62

Obesity and restless legs syndrome in men and women. Neurology (2009) 1.61

Interstrand DNA cross-links induced by alpha,beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc Chem Res (2008) 1.60

Management of acquired bronchobiliary fistula: A systematic literature review of 68 cases published in 30 years. World J Gastroenterol (2011) 1.59

Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Pain (2010) 1.59

Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer (2006) 1.59

Bis(2-amino-3H-benzothia-zolium) bis-(7-oxabicyclo-[2.2.1]heptane-2,3-dicarboxyl-ato)cobaltate(II) hexa-hydrate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.59

Evidence of recombination and genetic diversity in human rhinoviruses in children with acute respiratory infection. PLoS One (2009) 1.58

NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res (2010) 1.58

Bis(2-amino-3H-benzothia-zolium) bis-(7-oxabicyclo-[2.2.1]heptane-2,3-di-carbox-yl-ato)manganate(II) hexa-hydrate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.57

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma. Oral Oncol (2013) 1.57

Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes (2004) 1.54

Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. EMBO J (2007) 1.54

Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest (2015) 1.54

Epidemiologic study of the predisposing factors in erythema toxicum neonatorum. Dermatology (2005) 1.53

Axon guidance by diffusible chemoattractants: a gradient of netrin protein in the developing spinal cord. J Neurosci (2006) 1.51

Postresuscitation myocardial diastolic dysfunction following prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med (2008) 1.51

Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry. Eur J Nucl Med Mol Imaging (2014) 1.51

Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine (2008) 1.50

Risk factors for early postoperative complications after pneumonectomy for benign lung disease. Ann Thorac Surg (2013) 1.49

Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Proc Natl Acad Sci U S A (2013) 1.49

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. J Acquir Immune Defic Syndr (2013) 1.48

FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One (2009) 1.48

Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2). J Biol Chem (2008) 1.48

Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. J Hypertens (2012) 1.47

Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: a new ultrasound scoring system. Respirology (2012) 1.47

C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity (2013) 1.46

A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J Proteome Res (2009) 1.46

Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A (2006) 1.46

Diaqua-bis(5-carb-oxy-2-propyl-1H-imidazole-4-carboxyl-ato-κN,O)nickel(II) N,N-dimethyl-formamide disolvate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.45